Generic

Iron Polymaltose Complex

Indications

The use of Iron Polymaltose Complex is recommended for the following conditions:

• Treatment of latent iron deficiency and iron deficiency anemia, including macrocytic anemia, baby nutritional anemia, anemia caused by excessive bleeding, and anemia caused by infections and malignant illness.
• Iron deficiency anemia prevention and therapy before, during, and after pregnancy, as well as during lactation.
• To cover the required daily dietary requirements for preventive treatment of iron deficiency (RDA).

Pharmacology

Iron Polymaltose Complex is a polysaccharide-iron complex that is a new iron preparation for the treatment of anemia caused by iron deficiency. The production of hemoglobin and the oxidative process of living tissue both require iron, which is a vital component of the body. This product contains a stable combination of non-ionic ferric iron and poly maltose. When ferric iron comes into contact with the mucosal cell surface, this allows for regulated absorption. Because it is non-ionic, it does not produce free radicals and so eliminates all of the hazardous side effects associated with typical ionized iron salt preparations.

Dosage & Administration

The dosage and duration of therapy are dependent upon the extent of iron deficiency and should be taken as directed by the physician.

• Adults: 10 ml once or twice daily
• Children (6-12 years): 10 ml daily
• Children (2-6 years): 5 ml daily
• Premature infants & Infants: 3.33 mg of elemental iron/kg body weight.

Interaction

No interactions have been detected in general. Ionic interactions with foodstuff components (phytates, oxalates, tannin, etc.) and concurrently supplied medicaments (tetracycline, antacids) are rare since iron is complexly bound.

Contraindications

• In cases where iron excess is a possibility, such as a hemochromatosis, thalassemia, or haemosiderosis.
• If you are allergic to iron or any of the syrup’s other ingredients.

Side Effects

This medication is well tolerated by most people. Oral iron preparations may cause nausea, vomiting, constipation, or diarrhea, among other side effects.

Pregnancy & Lactation

Drug administration during the first trimester of pregnancy necessitates a careful evaluation of the potential risks versus the advantages to be achieved, and should only be done if clearly recommended. Iron therapy may be recommended for the remainder of the pregnancy, but only on the recommendation of a physician. Although iron is excreted in breast milk, it is not in clinically significant amounts.

Precautions & Warnings

After apparent recovery, epigastric discomfort, diarrhea, and vomiting may occur, as well as metabolic acidosis, seizures, and coma. The removal of excess iron from the alimentary canal before to absorption is dependent on speed for efficient therapy. An emetic should be administered first, followed by gastric lavage with 1 percent sodium bicarbonate and oral desferrioxamine administration to complex with residue.

Therapeutic Class

Oral Iron preparations

Storage Conditions

Keep the temperature below 30°C and away from light and moisture. Keep out of children’s reach.

Pharmaceutical Name

Incepta Pharmaceuticals Ltd.